1. Home
  2. BWEN vs CELU Comparison

BWEN vs CELU Comparison

Compare BWEN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWEN
  • CELU
  • Stock Information
  • Founded
  • BWEN N/A
  • CELU 2016
  • Country
  • BWEN United States
  • CELU United States
  • Employees
  • BWEN N/A
  • CELU N/A
  • Industry
  • BWEN Industrial Machinery/Components
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWEN Industrials
  • CELU Health Care
  • Exchange
  • BWEN Nasdaq
  • CELU Nasdaq
  • Market Cap
  • BWEN 42.7M
  • CELU 42.2M
  • IPO Year
  • BWEN N/A
  • CELU N/A
  • Fundamental
  • Price
  • BWEN $2.12
  • CELU $3.87
  • Analyst Decision
  • BWEN Strong Buy
  • CELU Buy
  • Analyst Count
  • BWEN 1
  • CELU 1
  • Target Price
  • BWEN $6.00
  • CELU $6.00
  • AVG Volume (30 Days)
  • BWEN 205.8K
  • CELU 65.9K
  • Earning Date
  • BWEN 08-12-2025
  • CELU 10-15-2025
  • Dividend Yield
  • BWEN N/A
  • CELU N/A
  • EPS Growth
  • BWEN N/A
  • CELU N/A
  • EPS
  • BWEN N/A
  • CELU N/A
  • Revenue
  • BWEN $145,141,000.00
  • CELU $54,220,000.00
  • Revenue This Year
  • BWEN $8.75
  • CELU $23.29
  • Revenue Next Year
  • BWEN $3.50
  • CELU N/A
  • P/E Ratio
  • BWEN N/A
  • CELU N/A
  • Revenue Growth
  • BWEN N/A
  • CELU 138.11
  • 52 Week Low
  • BWEN $1.41
  • CELU $1.00
  • 52 Week High
  • BWEN $3.03
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • BWEN 42.01
  • CELU 61.06
  • Support Level
  • BWEN $2.06
  • CELU $3.52
  • Resistance Level
  • BWEN $2.30
  • CELU $4.01
  • Average True Range (ATR)
  • BWEN 0.18
  • CELU 0.33
  • MACD
  • BWEN -0.03
  • CELU -0.00
  • Stochastic Oscillator
  • BWEN 33.33
  • CELU 65.62

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: